Tag: Government
New Opioid Rx Rules Coming for U.S. Employees’ Health Plans
New Federal Employee Health Benefits Program rules are meant to prevent overprescribing
State Public Health Workforce Grew From 2013 to 2017
Greater expertise in evaluation and applied research is needed to conduct essential services
Experts Address Loss of the National Guideline Clearinghouse
Demise of NGC in July 2018 is likely to impact evidence-based health care around the world
National Guideline Clearinghouse Offline Due to Funding Cuts
An initiative of AHRQ, guideline.gov now offline due to lack of federal funding
New Rules May Constrain Docs’ Ability to Treat Chronic Pain
Limitations on the use of prescription narcotics could complicate patient treatment
ASHP + Partners Urge Congress Action on Drug Shortages
Groups urge Congress to take immediate action, provide transparency and improve manufacturing
Budget Cuts Threaten Research on Antimicrobial Resistance
Patient safety, international status of the U.S. as leader in combating AMR both at risk
Surgeon General Dismissed by Trump Administration
Had served just over two years of his four-year term
Steep Rise in U.S. Drug Prices Tied to Patent Monopolies
Letting Medicare and Medicaid negotiate pricing would likely help bring costs down, researchers say
2017 Will Bring Premium Rate Increases Under ACA
Experts say increases will mostly affect people who get modest subsidies or no financial assistance